HomeRLAY • NASDAQ
Relay Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.68M | -23.26% |
Operating expense | 18.74M | -5.35% |
Net income | -77.07M | 5.31% |
Net profit margin | -1.00K | -23.40% |
Earnings per share | -0.46 | 25.81% |
EBITDA | -83.66M | 7.86% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 710.36M | -5.24% |
Total assets | 799.36M | -5.00% |
Total liabilities | 78.28M | -18.18% |
Total equity | 721.08M | — |
Shares outstanding | 171.44M | — |
Price to book | 0.69 | — |
Return on assets | -25.40% | — |
Return on capital | -26.61% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -77.07M | 5.31% |
Cash from operations | -73.21M | -45.48% |
Cash from investing | 42.47M | 303.24% |
Cash from financing | — | — |
Net change in cash | -30.75M | -436.75% |
Free cash flow | -48.20M | -95.91% |
Previous close
$2.93
Day range
$2.91 - $2.97
Year range
$1.78 - $10.72
Market cap
507.48M USD
Avg Volume
2.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
259
